GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Medicilon Inc (SHSE:688202) » Definitions » EV-to-Revenue

Shanghai Medicilon (SHSE:688202) EV-to-Revenue : 4.41 (As of Jun. 24, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Medicilon EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Shanghai Medicilon's enterprise value is ¥4,607 Mil. Shanghai Medicilon's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ¥1,045 Mil. Therefore, Shanghai Medicilon's EV-to-Revenue for today is 4.41.

The historical rank and industry rank for Shanghai Medicilon's EV-to-Revenue or its related term are showing as below:

SHSE:688202' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.57   Med: 10.04   Max: 54.19
Current: 4.41

During the past 11 years, the highest EV-to-Revenue of Shanghai Medicilon was 54.19. The lowest was 2.57. And the median was 10.04.

SHSE:688202's EV-to-Revenue is ranked better than
63.42% of 995 companies
in the Biotechnology industry
Industry Median: 7.6 vs SHSE:688202: 4.41

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-24), Shanghai Medicilon's stock price is ¥34.51. Shanghai Medicilon's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥7.84. Therefore, Shanghai Medicilon's PS Ratio for today is 4.40.


Shanghai Medicilon EV-to-Revenue Historical Data

The historical data trend for Shanghai Medicilon's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Medicilon EV-to-Revenue Chart

Shanghai Medicilon Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.03 25.42 11.27 6.30 3.75

Shanghai Medicilon Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.35 3.06 4.55 3.75 4.04

Competitive Comparison of Shanghai Medicilon's EV-to-Revenue

For the Biotechnology subindustry, Shanghai Medicilon's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Medicilon's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Medicilon's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shanghai Medicilon's EV-to-Revenue falls into.


;
;

Shanghai Medicilon EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Shanghai Medicilon's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4607.135/1045.33
=4.41

Shanghai Medicilon's current Enterprise Value is ¥4,607 Mil.
Shanghai Medicilon's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,045 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Medicilon  (SHSE:688202) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Shanghai Medicilon's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=34.51/7.836
=4.40

Shanghai Medicilon's share price for today is ¥34.51.
Shanghai Medicilon's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥7.84.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Medicilon EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai Medicilon's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Medicilon Business Description

Traded in Other Exchanges
N/A
Address
Lane 67, Libing Road, Building 5, Pilot Free Trade Zone, Shanghai, CHN, 201299
Shanghai Medicilon Inc is a comprehensive biomedical research and developemnt service company. It provides a full range of one-stop new drug development services for pharmaceutical companies and research institutions around the world in line with domestic and international reporting standards.
Executives
Chen Jin Zhang Director
Chen Guo Xing Director
Lin Zhang Qing Director
Peng Shuang Qing Core technical personnel
Li Zhi Gang Core technical personnel
Xu Yong Mei Core technical personnel
Liu Bin Bin senior management
Zhang Xiao Dong senior management
Xue Chao senior management
Ma Xing Quan senior management
Directors, senior managers, core technical personn
Cai Jin Na Directors, senior managers

Shanghai Medicilon Headlines

No Headlines